Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Available No phase listed Expanded access

Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis

ClinicalTrials.gov ID: NCT04474990

Public ClinicalTrials.gov record NCT04474990. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Jul 22, 2026, 12:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

VP-VLY-686-3303: Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis

Study identification

NCT ID
NCT04474990
Recruitment status
Available
Study type
Expanded access
Phase
Not listed
Lead sponsor
Vanda Pharmaceuticals
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • Tradipitant Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Aug 23, 2025

United States locations

U.S. sites
15
U.S. states
13
U.S. cities
15
Facility City State ZIP Site status
Vanda Investigational Site Maitland Florida 32751 Available
Vanda Investigational Site Tampa Florida 33613 Available
Vanda Investigational Site Wauconda Illinois 60084 Available
Vanda Investigational Site Wichita Kansas 67214 Available
Vanda Investigational Site Louisville Kentucky 40202 Available
Vanda Investigational Site Chevy Chase Maryland 20815 Available
Vanda Investigational Site Boston Massachusetts 02215 Available
Vanda Investigational Site Chesterfield Missouri 63005 Available
Vanda Investigational Site Charlotte North Carolina 28209 Available
Vanda Investigational Site Tulsa Oklahoma 74104 Available
Vanda Investigational Site Philadelphia Pennsylvania 19104 Available
Vanda Investigational Site Nashville Tennessee 37211 Available
Vanda Investigational Site Houston Texas 77084 Available
Vanda Investigational Site Plano Texas 75024 Available
Vanda Investigational Site Spokane Washington 99202 Available

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04474990, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 23, 2025 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04474990 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →